Duavee (Conjugated estrogens/Bazedoxifene) for Osteoporosis

Overview
Duavee is a prescription medication approved by the Food and Drug Administration (FDA) to treat moderate to severe vasomotor symptoms of menopause, such as hot flashes and night sweats, and prevent postmenopausal osteoporosis. Duavee is not indicated for women who have had their uterus removed by hysterectomy. Duavee is a combination drug composed of conjugated estrogens and Bazedoxifene.

Estrogens are hormones present at high levels in women of child-bearing age. Conjugated estrogens are a mix of estrogens designed to replace hormones in postmenopausal women. Bazedoxifene is a selective estrogen receptor modulator (SERM). Both conjugated estrogens and Bazedoxifene are believed to work by protecting bone density.

How do I take it?
Duavee is taken once daily. Ask your doctor whether you need to take daily calcium and vitamin D supplements while on Duavee.

Duavee is available as a tablet.

Side effects
The FDA-approved label for Duavee lists common side effects including dizziness, neck pain, sore throat, muscle spasms, upper abdominal pain, nausea, upset stomach, and diarrhea.

Rare but serious side effects listed for Duavee include increased risk for gallbladder disease, certain types of cancer, and cardiovascular problems such as blood clots and stroke; loss of vision, jaundice, and severe hypertriglyceridemia (high levels of blood fats).

For more details about this treatment, visit:

Duavee - Pfizer
https://www.duavee.com/